Skip to main content

Physician Search

 

Consuelo Wilkins, MD, MSCI, Senior Vice President for Health Equity and Inclusive Excellence for Vanderbilt University Medical Center (VUMC) and Senior Associate Dean for Health Equity and Inclusive Excellence for Vanderbilt University School of Medicine, always knew she wanted to be a physician. "Health equity was built into everything I did, even if I didn’t know it or recognize it at the time," Wilkins said. "I have always learned and believed that people are the same — everyone deserves to be healthy, and everyone should have the best opportunities to take care of themselves and their families." Click below to learn more about health equity initiatives.

https://momentum.vicc.org/2021/09/everyone-deserves-to-be-healthy/
Vanderbilt was the lead site for an NIH-funded, phase 2, multicenter influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant (HCT) recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population. Natasha Halasa, MD, MPH and colleagues recently published in the New England Journal of Medicine, that two doses of high-dose trivalent flu vaccine resulted in higher amounts of influenza-specific antibodies than two doses of standard dose quadrivalent vaccine.

https://news.vumc.org/2023/03/02/high-dose-flu-vaccine-beneficial-for-pediatric-stem-cell-transplant-patients/

Displaying 201 - 210 of 299

TRISOL: EARLY FEASIBILITY STUDY OF THE TRISOL SYSTEM PROTOCOL

Not Available
Goel, Kashish
VALV0008



ACCESS-MANTA Registry - Prospective Clinical Registry evaluating contemporary MANTA outcomes (ACCESS-MANTA Registry)

Not Available
Goel, Kashish
CRE-INT0012

SENSATION: TREATMENT OF SYMPTOMATIC DRUG REFRACTORY PAROXYSMAL ATRIAL FIBRILLATION WITH THE SYNAPTIC COMPLIANT CRYOABLATION BALLOON AND SYSTEM

Not Available
Richardson, Travis
CRE-ARR0022

FULCRUM VT- Cryoablation for Monomorphic Ventricular Tachycardia IDE Early Feasibility Study

Not Available
Stevenson, William
CRE-ARR0019

CY 6022 - A FOLLOW-UP, OPEN-LABEL, RESEARCH EVALUATION OF SUSTAINED TREATMENT WITH AFICAMTEN (CK-3773274) IN HYPERTROPHIC CARDIOMYOPATHY (HCM)

Not Available
Brinkley, Douglas
CRE-CHF0014

Equity in Modifying Plaque Of WomEn with UndeRtreated Calcified Coronary Artery Disease (EMPOWER CAD)

Not Available
Sutton, Nadia
CRE-CHF0017

A Pivotal, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System™ Kit, in Subjects with Hypertension

Not Available
III
Not Available
NCT02910414
CRE-INT0003